Ariel Ruiz Urquiola, a Cuban scientist and dissident forced to flee into exile, confronted Manu Pineda and other MEPs who support Cuba’s murderous communist dictatorship in Brussels.
Via ADN Cuba (my translation):
Airel Ruiz Urquiola confronts EU Member of Parliament Manu Pineda
Cuban activist Ariel Ruiz Urquiola confronted left-wing MEP Manu Pineda and a delegation that supports the Cuban Castro regime on Tuesday in Brussels.
Ruiz Urquiola showed them what the Cuban regime does to women suffering from breast cancer, like his sister Omara, who had to leave the country to receive treatment and is prevented from returning by the regime.
While Ariel ran with a banner featuring images referring to breast cancer, other activists chanted slogans in support of freedom for Cuba.
Pineda’s support for the Cuban regime became evident in November 2021 when he referred to the November 15th March as ‘a campaign of destabilization’ allegedly orchestrated from Miami.
On that occasion, the Spanish MEP visited Cuba and met with the Cuban dictator Miguel Díaz-Canel.
In 2020, Ariel denounced the poor performance of Cuban healthcare institutions in his sister’s case. The National Institute of Oncology and Radiobiology (INOR) in Havana disrupted Omara’s treatment to the detriment of her survival.
In January of that year, Omara was incorrectly administered the monoclonal antibody Pertuzumab, given subcutaneously instead of intravenously. The consequences of this improper administration began to manifest the following day. The opposition activist experienced fatigue and respiratory problems during a trip to Colombia, in addition to developing skin lesions.
Despite the evident harm, the doctor who had been treating her since 2005, Braulio Mestre, refused to advance the treatment scheduled for February, causing concern for the family.
The doctor obstructed access to the necessary immunotherapy for the patient.
At that time, Ariel proposed taking the case to the World Health Organization (WHO). Omara Ruiz Urquiola is the only survivor among the breast cancer patients admitted to INOR in 2005.